Developing a new mouse model to speed up malaria vaccine creation
Accelerating Malaria Vaccines with a Custom Preclinical Humanized Mouse Model Platform
This study is creating special mice that act like humans to help test new malaria vaccines, making it easier to find the best options to protect people from this disease.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Massachusetts General Hospital NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-11041181 on NIH RePORTER |
What this research studies
This research focuses on creating a specialized mouse model that mimics the human immune response to malaria, which is crucial for testing new vaccines. By using innovative techniques to generate mice with human-like B cells, the researchers aim to enhance the screening and development of malaria vaccines targeting the sporozoite stage of the parasite. The project will involve immunizing these mice with specific protein fragments to identify the most effective vaccine candidates. This approach could lead to faster and more effective malaria vaccines, ultimately improving public health outcomes.
Who could benefit from this research
Good fit: Ideal candidates for benefiting from this research include children under 11 years old, particularly those living in malaria-endemic regions.
Not a fit: Patients who are not affected by malaria or those who are older than 11 years may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of more effective malaria vaccines, significantly reducing the incidence and mortality of malaria in children and vulnerable populations.
How similar studies have performed: Other research has shown success in using humanized mouse models for vaccine development, indicating that this approach has potential for breakthroughs in malaria vaccine efficacy.
Where this research is happening
Boston, United States
- Massachusetts General Hospital — Boston, United States (Active)
Researchers
- Principal investigator: Batista, Facundo Damian — Massachusetts General Hospital
- Study coordinator: Batista, Facundo Damian
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.